Inhibition of preterm labor and subcutaneous terbutaline therapy

Multiple Pregnancy: Epidemiology, Gestation, and Perinatal Outcome

Volumn , Issue , 2007, Pages 601-625

  Lam, F ^a   Gill, P ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85127988944     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Creasy RK, Katz M. Basic research and clinical experience with ß-adrenergic tocolytics in the United States. In Fuchs F, Stubblefield PG, eds. Preterm Birth: Causes, Prevention and Management. Toronto: MacMillan, 1984:150-70
2. Lam F, Elliott J, Jones S, et al. Clinical issues surrounding the use of terbutaline sulphate for preterm labor. Obstet Gynecol Surv 1998;53:S85-95
3. Downey LJ, Martin AJ. Ritodrine in the treatment of preterm labour: a study of 213 patients. Br J Obstet Gynaecol 1983; 90:1046-53
4. Nageotte MP. Prevention and treatment of preterm labor in twin gestation. Clin Obstet Gynecol 1990;33:61-8
5. Sanchez-Ramos L, Kaunitz AM, Gaudier FL, et al. Efficacy of maintenance therapy after acute tocolysis: a meta analysis. Am J Obstet Gynecol 1999;181:484-90
6. Russell JK. Maternal and fetal hazards associated with twin pregnancies. J Obstet Gynaecol Br Emp 1952;59:208
7. Powers WF, Miller TC. Bedrest in twin pregnancy: identification of a critical period and its cost implications. Am J Obstet Gynecol 1979;134:23
8. Newton ER. Antepartum care in multiple gestation. Semin Perinatol 1986;10:19-29
9. Luke B, Keith L, Witter F. Theoretical model for reducing neonatal morbidity and mortality and associated cost among twins. J Matern Fetal Med 1992;1:14-19
10. Smyth CN. The guard-ring tocodynamometer: absolute assessment of intra-amniotic pressure by a new instrument. J Obstet Gynaecol Br Commonw 1957;64:59
11. Alvarez H, Caldeyro R. Contractility of the human uterus recorded by new methods. Surg Gynecol Obstet 1950; 91:1
12. Creasy RK. Preterm labor and delivery. In Creasy RK, Resnick R, eds. Maternal-Fetal Medicine, Principles and Practice. Philadelphia: WB Saunders, 1984:415-43
13. Newman RB, Gill PG, Campion S. Antepartum ambulatory tocodynamometry: the significance of low-amplitude, high-frequency contractions. Obstet Gynecol 1987;70:701
14. Kawarabayashi T, Kuriyama K, Kishikawa T. Clinical features of small contraction wave recorded by an external toco-dynamometer. Am J Obstet Gynecol 1988;158:474-8
15. Nakae S. Analysis of uterine contraction in late pregnancy and premature labor. Acta Obstet Gynaecol Jpn 1978;30:1637
16. Warkentin B. Die uterine Aktivität in der Spatschwangerschaft. Z Geburtsh Perinat 1976;180:225
17. Scheerer L, Katz MM. Home monitoring for preterm labor. In Parer JT, ed. Antepartum and Intrapartum Management. Philadelphia: Lea and Febiger, 1989:32-52
18. Newman RB, Gill PJ, Campion S, et al. The influence of fetal number on antepartum uterine activity. Obstet Gynecol 1989; 73:695
19. Lam F, Gill P, Smith M, et al. Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol 1988; 72:810-13
20. Schwenzer TH, Schumann R, Halberstadt E. The importance of 24 hour cardiotocographic monitoring during tocolytic therapy. In Jung H, Lamberti G, eds. Beta-mimetic Drugs in Obstetrics and Perinatology. New York: Thieme-Stratton, 1982:60
21. Zahn V. Uterine contractions during pregnancy. J Perinat Med 1984;12:107
22. Arakai R. The investigations of the effect of daily activity on the uterine contractions during pregnancy. Acta Obstet Gynaecol Jpn 1984;36:589
23. Lam F. Miniature pump infusion of terbutaline - an option in preterm labor. Contemp Obstet Gynecol 1989;33:53
24. Gill P, Smith M, McGregor C. Terbutaline by pump to prevent recurrent preterm labor. Matern Child Nurs 1989;14:163-7
25. Sala DJ, Moise KJ. The treatment of preterm labor using a portable subcutaneous terbutaline pump. J Obstet Gynecol Neonat Nurs 1989;19:108-15
26. Stanton RJ. Comanagement of the patient on subcutaneous terbutaline pump therapy. J Nurse-Midwifery 1991; 36:204-8
27. Garite TJ, Bentley DL, Hamer CA, et al. Uterine activity characteristics in multiple gestations. Obstet Gynecol 1990; 76:56S-9S
28. Lam F, Gill PJ, Smith M, et al. Comparison of portable subcutaneous terbutaline pump and oral terbutaline treatment for long-term tocolysis; a randomized clinical trial. Presented at the Eighth Annual Meeting, Society of Perinatal Obstetricians, Las Vegas, Nevada, February 1988:abstr 400
29. Allbert JR, Johnson C, Roberts WE, et al. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump. J Reprod Med 1994;39:614
30. Allbert JR, Wise CA, Lou CH, et al. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth. J Perinatol 1992;12:28-31
31. Adkins RT, Van Hooydonk JE, Bressman PL, et al. Prevention of preterm birth; early detection and aggressive treatment with terbutaline. South Med J 1993;86:157-64
32. Wenstrom KD, Weiner CP, Merrill D, et al. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery. J Perinatol 1997;14:87-91
33. Guinn DA, Goepfert AR, Owen J, et al. Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial. Am J Obstet Gynecol 1998;179:874-8
34. Elliott JP, Bergauer NK, Jacques DL, et al. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline. J Reprod Med 2001;46:975-82
35. Lam F, Bergauer NK, Stanziano GJ, et al. Pregnancy prolongation and route of tocolytic administration in patients with singleton gestation. Am J Obstet Gynecol 1998:178:S180
36. Lam F, Bergauer NK, Coleman SK, et al. A comparison of gestational days gained with oral terbutaline vs. continuous subcutaneous terbutaline in women with twin gestations. J Perinatol 2000;20:408-13
37. Elliott JP, Radin TG. Quadruplet pregnancy: contemporary management and outcome. Obstet Gynecol 1992;80: 421-4
38. Angel JL, Kalter CS, Morales WJ, et al. Aggressive perinatal care for high-order multiple gestations: does good perinatal outcome justify aggressive assisted reproductive techniques? Am J Obstet Gynecol 1999;181:253-9
39. Morrison JC, Chauhan SP, Carroll CS, et al. Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor. Am J Obstet Gynecol 2003;188:1460-7
40. Elliott JP, Istwan NB, Rhea D, et al. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy. American College of Obstetricians and Gynecologists, 50th Annual Clinical Meeting. May, 2002. Am J Obstet Gynecol 2004;in press
41. Hudgens DR, Conradi SE. Sudden death associated with terbutaline sulphate administration. Am J Obstet Gynecol 1993; 169:120-1
42. Lam F, Istwan NB, Jacques D, et al. Managing perinatal outcomes: the clinical- and cost-effectiveness of pharmacologic treatment of recurrent preterm labor. Managed Care 2003;12:39-46
43. Streitman D, Caritis SN, Parilla BV. Should maintenance tocolytics play a role in the prevention of preterm birth? Contemp Obstet Gynecol 2001;46:11
44. How HY, Hughes SA, Vogel RL, et al. Oral terbutaline in the outpatient management of preterm labor. Am J Obstet Gynecol 1995;173:1518-22
45. Marivate M, DeVilliers KQ, Fairbrother P. Effect of prophylactic outpatient administration of feneterol on the time of onset of spontaneous labor and fetal growth rate in twin pregnancy. Am J Obstet Gynecol 1977;128:707
46. Skjaerris J, Aberg A. Prevention of prematurity in twin pregnancy by orally administered terbutaline. Acta Obstet Gynecol Scand 1982;108(Suppl):39
47. Cetrulo CL, Freeman RK. Ritodrine HCl for the prevention of premature labor in twin pregnancies. Acta Genet Med Gemellol Roma 1976;25:321
48. O'Connor MC, Murphy H, Dalymple IJ. Double blind trial of ritodrine and placebo in twin pregnancy. Br J Obstet Gynaecol 1979;86:706
49. Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308
50. Berg G, Andersson RGG, Rygen G. ß-Adrenergic receptors in human myometrium during pregnancy: changes in the number of receptors after ß-mimetic treatment. Am J Obstet Gynecol 1985;151:392
51. Casper RF, Lye SJ. Myometrial desensitization to continuous but not to intermittent beta-adrenergic agonist infusion in sheep. Am J Obstet Gynecol 1986;154:301
52. Fredholm BB, Lunell N, Persson B, et al. Development of tolerance to the metabolic actions of ß2-adrenoceptor stimulating drugs. Acta Obstet Gynecol Scand 1982;18(Suppl):53-9
53. Mickey J, Tate R, Lefkowitz RJ. Subsensitivity of adenylate cyclase and decreased ß-adrenergic receptor binding after chronic exposure to (-) isoproterenol in vitro. J Biol Chem 1975;250:5727
54. Ryden G, Rolf G, Andersson G, et al. Is the relaxing effect of ß-adrenergic agonists on the human myometrium only transitory? Acta Obstet Gynecol Scand 1982;108(Suppl):47
55. Swillens S, Lefort E, Barber R, et al. Consequences of hormone-induced desensitization of adenylate cyclase in intact cells. Biochem J 1980;188:169
56. Beall M, Edgar B, Paul R, et al. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985;153:857-9
57. Valenzuela G, Cline S. Use of magnesium sulphate in premature labor that fails to respond to ß-mimetic drugs. Am J Obstet Gynecol 1982;143:718
58. Miller JM, Keane M, Horger EO. A comparison of magnesium sulphate and terbutaline for the arrest of premature labor: a preliminary report. J Reprod Med 1982;27:348-51
59. Hollander D, Nagey D, Pupkin M. Magnesium sulphate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987;156:631
60. Elliott JP. Magnesium sulfate as a tocolytic agent. Am J Obstet Gynecol 1983;147:277
61. Ridgway LE, Muise K, Wright JW, et al. A prospective randomized comparison of oral terbutaline and magnesium oxide for the maintenance of tocolysis. Am J Obstet Gynecol 1990;163:879-82
62. Martin RW, Martin JN, Morrison JC, et al. Comparison of oral ritodrine and magnesium gluconate for ambulatory tocolysis. Am J Obstet Gynecol 1988;158:1440-5
63. Martin RW, Gaddy DK, Morrison JC, et al. Tocolysis with oral magnesium. Am J Obstet Gynecol 1987;156:433-4
64. Repke J, Niebyl J. The role of prostaglandin synthetase inhibitors in the treatment of preterm labor. Semin Reprod Endocrinol 1985;3:259
65. Niebyl JR, Witter FR. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol 1986;155: 747-9
66. Vermillion ST, Scardo JA, Lashus AG, et al. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997;177:256
67. Dudley D, Hardie M. Fetal and neonatal effects of indomethacin used as a tocolytic agent. Am J Obstet Gynecol 1985;151:181-4
68. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974;44:787-92
69. Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol 1990;76:689-92
70. Kirshon B, Moise KJ, Wasserstrum N, et al. Influence of short-term indomethacin therapy on fetal urine output. Obstet Gynecol 1988;72:51-3
71. Read MD, Wellby DE. The use of calcium antagonists (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 1986;93:933-7
72. Carr DB, Clark AL, Kernek K, et al. Maintenance oral nifedipine for preterm labor: a randomized clinical trial. Am J Obstet Gynecol 1999;181:822-7
73. Dahlberg NL. A perinatal center based antepartum home-care program. J Obstet Gynecol Neonat Nurs 1988;17:30-4
74. Katz M, Gill PJ, Newman RB. Detection of preterm labor by ambulatory monitoring of uterine activity: a preliminary report. Obstet Gynecol 1986;68:773-8
75. Katz M, Gill PJ, Newman RB. Detection of preterm labor by ambulatory monitoring of uterine activity for the management of oral tocolysis. Am J Obstet Gynecol 1986;154: 1253-6
76. Knuppel RA, Lake MF, Watson DL, et al. Preventing preterm birth in twin gestation: home uterine activity monitoring and perinatal nursing support. Obstet Gynecol 1990;76: 24S-7S